Cardinal Health's stock has shown strong recent performance, rising 3.3% in the last week and an impressive 81.1% year-to-date, attracting both growth and value investors. The company has secured major contract wins and formed new partnerships within the healthcare supply chain, fueling market optimism about its strengthened industry position. Wall Street analysts maintain a 'Buy' rating on the stock, though some caution exists regarding the potential over-optimism of these recommendations. The rally is being questioned for its long-term justification.